BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 38399524)

  • 1. Targeted next-generation sequencing of 491 lung cancers in clinical practice: Implications for future detection strategy and targeted therapy.
    Liu XD; Zhang Y; He HY
    Heliyon; 2024 Mar; 10(6):e27591. PubMed ID: 38496837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characterization of next-generation sequencing detected mutations in lung cancers-a single-center experience.
    Walter J; Tufman A; Kumbrink J; Neumann J; Kahnert K; Sellmer L; Jung A; Behr J; Kauffmann-Guerrero D
    Transl Lung Cancer Res; 2024 Apr; 13(4):799-810. PubMed ID: 38736491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.
    Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
    JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing Trends among Adult Patients with Select Advanced Tumor Types: A Real-World Evidence Evaluation.
    Ferreira-Gonzalez A; Hocum B; Ko G; Shuvo S; Appukkuttan S; Babajanyan S
    J Mol Diagn; 2024 Apr; 26(4):292-303. PubMed ID: 38296192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review.
    Sharma P; Mahadevia H; Donepudi S; Kujtan L; Gustafson B; Ponvilawan B; Al-Obaidi A; Subramanian J; Bansal D
    Clin Lung Cancer; 2024 Apr; ():. PubMed ID: 38777674
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between Radiological Characteristics, PET-CT and Histological Subtypes of Primary Lung Adenocarcinoma-A 102 Case Series Analysis.
    Colic N; Stevic R; Stjepanovic M; Savić M; Jankovic J; Belic S; Petrovic J; Bogosavljevic N; Aleksandric D; Lukic K; Kostić M; Saponjski D; Vasic Madzarevic J; Stojkovic S; Ercegovac M; Garabinovic Z
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674262
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
    Gelatti ACZ; Drilon A; Santini FC
    Lung Cancer; 2019 Nov; 137():113-122. PubMed ID: 31568888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer].
    Wang R; Pan S; Song X
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):174-182. PubMed ID: 35340160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing in Lung Cancers-A Single-Center Experience in Taiwan.
    Lai WA; Huang YS; Chang KC; Yang SF; Yang CJ; Liu YW; Chen HD
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399524
    [No Abstract]   [Full Text] [Related]  

  • 10. A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
    Heredia D; Mas L; Cardona AF; Oyervides V; Motta Guerrero R; Galvez-Nino M; Lara-Mejía L; Aliaga-Macha C; Carracedo C; Varela-Santoyo E; Ramos-Ramírez M; Davila-Dupont D; Martínez J; Cruz-Rico G; Remon J; Arrieta O
    Lung Cancer; 2022 Dec; 174():133-140. PubMed ID: 36379126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation Profile of Resected
    Zhao ZR; Lin YB; Ng CSH; Zhang R; Wu X; Ou Q; Chen W; Zhou WJ; Lin YB; Su XD; Shao YW; Long H
    Oncologist; 2019 Oct; 24(10):1368-1374. PubMed ID: 30872465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
    Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third-generation TKI outcomes.
    Li Y; Zhang F; Yuan P; Guo L; Jianming Y; He J
    Thorac Cancer; 2020 Jun; 11(6):1503-1511. PubMed ID: 32285618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
    Wang HY; Ho CC; Lin YT; Liao WY; Chen CY; Shih JY; Yu CJ
    JCO Precis Oncol; 2024 Jan; 8():e2300314. PubMed ID: 38190582
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.